These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15858454)

  • 1. Descriptive epidemiology of affective disorders in multiple sclerosis.
    Patten SB; Svenson LW; Metz LM
    CNS Spectr; 2005 May; 10(5):365-71. PubMed ID: 15858454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective disorders in motor neuron disease: a population-based study.
    Patten SB; Svenson LW; White CM; Khaled SM; Metz LM
    Neuroepidemiology; 2007; 28(1):1-7. PubMed ID: 17164563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data.
    O'Donnell S; Vanderloo S; McRae L; Onysko J; Patten SB; Pelletier L
    Epidemiol Psychiatr Sci; 2016 Aug; 25(4):360-9. PubMed ID: 26081585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada.
    Svenson LW; Woodhead SE; Platt GH
    Neuroepidemiology; 1994; 13(1-2):8-13. PubMed ID: 8190211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of administrative data for the surveillance of mood and anxiety disorders.
    Kisely S; Lin E; Gilbert C; Smith M; Campbell LA; Vasiliadis HM
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1118-25. PubMed ID: 20001410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic disorders in MS: population-based evidence of an association.
    Patten SB; Svenson LW; Metz LM
    Neurology; 2005 Oct; 65(7):1123-5. PubMed ID: 16217073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
    Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
    J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multiple sclerosis in First Nations people of Alberta.
    Svenson LW; Warren S; Warren KG; Metz LM; Patten SB; Schopflocher DP
    Can J Neurol Sci; 2007 May; 34(2):175-80. PubMed ID: 17598594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective disorders and multiple sclerosis: a controlled study on 65 Italian patients.
    Salmaggi A; Palumbo R; Fontanillas L; Eoli M; La Mantia L; Solari A; Pareyson D; Milanese C
    Ital J Neurol Sci; 1998 Jun; 19(3):171-5. PubMed ID: 10933472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and affective disorder. Family history, sex, and HLA-DR antigens.
    Schiffer RB; Weitkamp LR; Wineman NM; Guttormsen S
    Arch Neurol; 1988 Dec; 45(12):1345-8. PubMed ID: 3196194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the burden of psychiatric comorbidity in MS vs the general population.
    Marrie RA; Fisk JD; Tremlett H; Wolfson C; Warren S; Tennakoon A; Leung S; Patten SB;
    Neurology; 2015 Dec; 85(22):1972-9. PubMed ID: 26519542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mental health care use by mothers of children with multiple sclerosis.
    Marrie RA; O'Mahony J; Maxwell C; Ling V; Yeh EA; Arnold DL; Bar-Or A; Banwell B;
    Neurology; 2020 Mar; 94(10):e1040-e1050. PubMed ID: 31919112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
    Kingwell E; Zhu F; Marrie RA; Fisk JD; Wolfson C; Warren S; Profetto-McGrath J; Svenson LW; Jette N; Bhan V; Yu BN; Elliott L; Tremlett H
    J Neurol; 2015 Oct; 262(10):2352-63. PubMed ID: 26205633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.
    Warren SA; Svenson LW; Warren KG
    Mult Scler; 2008 Aug; 14(7):872-9. PubMed ID: 18573834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
    Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of mental illness and its impact on the use of home care and nursing homes: a population-based study of older adults in Manitoba.
    Martens PJ; Fransoo R; Burland E; Burchill C; Prior HJ; Ekuma O;
    Can J Psychiatry; 2007 Sep; 52(9):581-90. PubMed ID: 17953162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiological investigation of affective disorders with a population-based cohort of 1023 adults with intellectual disabilities.
    Cooper SA; Smiley E; Morrison J; Williamson A; Allan L
    Psychol Med; 2007 Jun; 37(6):873-82. PubMed ID: 17274854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
    Marrie RA; Yu N; Blanchard J; Leung S; Elliott L
    Neurology; 2010 Feb; 74(6):465-71. PubMed ID: 20071664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Affective and psychotic disorders in multiple sclerosis].
    Pozuelo-Moyano B; Benito-León J
    Rev Neurol; 2015 Dec; 61(11):503-8. PubMed ID: 26602805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.